GESULLO, FRANCESCA
 Distribuzione geografica
Continente #
NA - Nord America 2.373
EU - Europa 1.472
AS - Asia 1.063
SA - Sud America 96
Continente sconosciuto - Info sul continente non disponibili 50
AF - Africa 38
OC - Oceania 9
Totale 5.101
Nazione #
US - Stati Uniti d'America 2.327
IT - Italia 459
RU - Federazione Russa 458
CN - Cina 293
SG - Singapore 292
DE - Germania 161
HK - Hong Kong 149
FI - Finlandia 93
VN - Vietnam 82
KR - Corea 80
BR - Brasile 75
IE - Irlanda 59
FR - Francia 57
SE - Svezia 46
BD - Bangladesh 39
CH - Svizzera 37
CA - Canada 35
NL - Olanda 35
IN - India 29
JO - Giordania 26
GB - Regno Unito 25
TW - Taiwan 17
ES - Italia 16
ID - Indonesia 11
JP - Giappone 11
AR - Argentina 10
AU - Australia 9
IQ - Iraq 8
AT - Austria 7
CI - Costa d'Avorio 7
NG - Nigeria 7
ZA - Sudafrica 7
MX - Messico 6
MY - Malesia 5
AL - Albania 4
EG - Egitto 4
PK - Pakistan 4
PL - Polonia 4
EC - Ecuador 3
KE - Kenya 3
MA - Marocco 3
PH - Filippine 3
RO - Romania 3
UA - Ucraina 3
AE - Emirati Arabi Uniti 2
CL - Cile 2
CO - Colombia 2
DZ - Algeria 2
GE - Georgia 2
LT - Lituania 2
NP - Nepal 2
UZ - Uzbekistan 2
VE - Venezuela 2
XK - ???statistics.table.value.countryCode.XK??? 2
BJ - Benin 1
BO - Bolivia 1
BW - Botswana 1
CR - Costa Rica 1
ET - Etiopia 1
GR - Grecia 1
JM - Giamaica 1
KW - Kuwait 1
KZ - Kazakistan 1
MT - Malta 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
PR - Porto Rico 1
SA - Arabia Saudita 1
SI - Slovenia 1
SN - Senegal 1
TH - Thailandia 1
TN - Tunisia 1
TR - Turchia 1
TT - Trinidad e Tobago 1
Totale 5.053
Città #
Santa Clara 446
Ashburn 252
Singapore 204
Hong Kong 129
Munich 128
San Jose 99
Fairfield 89
Seoul 80
Chandler 70
Hefei 70
Milan 68
Helsinki 67
Dublin 59
Beijing 58
Florence 49
Woodbridge 44
Council Bluffs 42
Los Angeles 42
Houston 41
Wilmington 41
Cambridge 40
Seattle 40
Bern 35
Ho Chi Minh City 32
New York 31
Rome 31
Buffalo 29
Altamura 24
Lauterbourg 22
Lawrence 22
The Dalles 22
Atlanta 21
Dallas 20
Paris 19
Princeton 16
Turku 15
Figino 14
Hanoi 14
Kent 14
Moscow 14
Taipei 14
Ann Arbor 13
London 12
Mumbai 12
Phoenix 12
Toronto 12
Boston 10
Orem 10
Shanghai 10
Montreal 9
Naples 9
Bremen 8
Chennai 8
Düsseldorf 8
Frankfurt am Main 8
Jakarta 8
Medford 8
Melbourne 8
Tokyo 8
Waltham 8
Abidjan 7
Barcelona 7
Boardman 7
Brooklyn 7
Fiesole 7
Genoa 7
Lappeenranta 7
São Paulo 7
Abuja 6
Amsterdam 6
Baghdad 6
Bologna 6
Clifton 6
Da Nang 6
Miano 6
Pian di Scò 6
Redondo Beach 6
San Diego 6
Bengaluru 5
Brescia 5
Johannesburg 5
Vienna 5
Biên Hòa 4
Dearborn 4
Dhaka 4
Modena 4
Padua 4
Phú Nhuận 4
San Francisco 4
Turin 4
Verona 4
Bari 3
Brasília 3
Cairo 3
Charlotte 3
Chicago 3
Denver 3
Faenza 3
Falkenstein 3
Fontebuona 3
Totale 2.947
Nome #
Spectrum of ASXL1 mutations in primary myelofibrosis: Prognostic impact of the ASXL1 p.G646Wfs∗12 mutation 402
Screening for Hereditary Alpha-Tryptasemia in Subjects with Systemic Mastocytosis (SM) and Non-SM Mast Cell Activation Symptoms 351
Validation of the Mayo alliance prognostic system for mastocytosis 346
Histopathology and Molecular Genetics in Systemic Mastocytosis: Implications for Clinical Management 308
Clinical presentation and management practice of systemic mastocytosis. A survey on 460 Italian patients 255
Involvement of RUNX1 Pathway Is a Common Event in the Leukemic Transformation of Chronic Myeloproliferative Neoplasms (MPNs) 233
Myelodysplasia as assessed by multiparameter flow cytometry refines prognostic stratification provided by genotypic risk in systemic mastocytosis 210
Germline transmission of LNKE208Q variant in a family with myeloproliferative neoplasms 202
Mutation landscape in patients with myelofibrosis receiving ruxolitinib or hydroxyurea 199
Clinical impact of mutated JAK2 allele burden reduction in polycythemia vera and essential thrombocythemia 194
The prognostic contribution of CBL, NRAS, KRAS, RUNX1, and TP53 mutations to mutation-enhanced international prognostic score systems (MIPSS70/plus/plus v2.0) for primary myelofibrosis 190
Ropeginterferon versus Standard Therapy for Low-Risk Patients with Polycythemia Vera 190
One thousand patients with essential thrombocythemia: the Florence-CRIMM experience 180
Integration of multiparameter flow cytometry score improves prognostic stratification provided by standard models in primary myelofibrosis 180
Disease correlates and clinical relevance of hereditary α-tryptasemia in patients with systemic mastocytosis 177
Gene expression profile correlates with molecular and clinical features in patients with myelofibrosis 165
Clinical and molecular predictors of fibrotic progression in essential thrombocythemia: A multicenter study involving 1607 patients 162
Clinical, Molecular, and Histopathological Correlates in a Series of 24 Consecutive Cases of Suspected Myeloproliferative Neoplasms with a JAK2V617F Variant Allele Frequency≤ 1% 161
Nanopore sequencing for the screening of myeloid and lymphoid neoplasms with eosinophilia and rearrangement of PDGFRα, PDGFRβ, FGFR1 or PCM1-JAK2 160
Prognotic Impact of Mutations in Systemic Mastocytosis 159
A case of aleukemic mast cell leukemia with an underlying myeloproliferative neoplasm: Morphological and molecular characteristics of a highly aggressive disease 154
Diagnostic and therapeutic challenges in mast cell sarcoma 152
Increased plasma levels of lncrnas linc01268, gas5 and malat1 correlate with negative prognostic factors in myelofibrosis 144
Ropeginterferon phase 2 randomized study in low-risk polycythemia vera: 5-year drug survival and efficacy outcomes 109
Changes in neutrophil-to-lymphocyte ratio in patients with polycythemia vera treated with ruxolitinib reflect JAK2 variant allele frequency 100
Combinatorial BCL2/BCL2L1 expression predicts clinical response to ruxolitinib in myelofibrosis 18
Totale 5.101
Categoria #
all - tutte 14.383
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.383


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202295 0 0 16 1 0 4 0 20 1 2 19 32
2022/2023424 25 72 27 22 22 53 41 19 59 12 18 54
2023/2024285 18 18 29 20 38 26 16 56 7 20 19 18
2024/20251.566 41 115 91 225 365 221 101 94 92 60 74 87
2025/20261.604 216 196 164 138 153 58 181 60 97 137 50 154
2026/2027770 113 550 107 0 0 0 0 0 0 0 0 0
Totale 5.101